<DOC>
	<DOCNO>NCT02829099</DOCNO>
	<brief_summary>The primary purpose study determine recommend Phase 2 dose ( RP2D ) schedule JNJ-64457107 administer intravenously ( IV ) participant advanced stage solid tumor Part 1 characterize safety JNJ-64457107 administer IV participant non-small cell lung cancer ( NSCLC ) , pancreatic cancer cutaneous melanoma Part 2 .</brief_summary>
	<brief_title>A Study Safety , Pharmacokinetics Pharmacodynamics JNJ-64457107 Participants With Advanced Stage Tumors</brief_title>
	<detailed_description />
	<criteria>Part 1 : advanced stage solid tumor ; Part 2 : nonsmall cell lung cancer ( NSCLC ) , pancreatic cancer cutaneous melanoma Eastern cooperative oncology group ( ECOG ) performance score 0 1 Adequate organ function define protocol A woman childbearing potential must negative highly sensitive serum ( betahuman chorionic gonadotropin [ betahCG ] ) pregnancy test Screening negative urine pregnancy test prior first dose study drug During study least 120 day receive last dose study drug , addition highly effective method contraception , man sexually active woman childbearing potential must agree use barrier method contraception ( example [ eg . ] , condom spermicidal foam/gel/film/cream/suppository ) , sexually active woman pregnant must use condom Malignancy disease study within 2 year screen ( exception squamous basal cell carcinoma skin carcinoma situ cervix , malignancy opinion investigator , concurrence sponsor 's medical monitor , consider cure minimal risk recurrence ) Symptomatic brain metastasis ; asymptomatic brain metastasis allow provide treat , stable great ( &gt; ) 6 week document radiographic imaging , require prolong ( &gt; 14 day ) systemic corticosteroid therapy Treatment local systemic antineoplastic therapy investigational anticancer agent within 14 day 4 halflives , whichever longer , maximum washout period 28 day prior initiation study drug administration Toxicities previous anticancer therapy resolve baseline level Grade 1 less except alopecia peripheral neuropathy Major surgery ( eg. , require general anesthesia ) within 3 week screen , fully recover surgery , surgery plan time subject expect participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>